Literature DB >> 11077320

Lipid risk profile and weight stability after gastric restrictive operations for morbid obesity.

R E Brolin1, L J Bradley, A C Wilson, R P Cody.   

Abstract

There are no longitudinal data that address weight loss stability and lipid levels in bariatric surgical patients. The goal of this study was to determine whether weight regain adversely affected reduction in lipid levels after gastric bariatric operations. Of 651 consecutive patients undergoing gastric restrictive surgery for morbid obesity, 227 (35%) had increased serum levels of total cholesterol (TC), triglycerides, or both preoperatively. High-density lipoprotein cholesterol (HDL-C) levels were subnormal (</=35 mg/dl) in 45 (20%) of the hyperlipidemic patients. Fasting lipid profiles were determined at 6-month intervals postoperatively. This series included the following three operations: gastroplasty (GP; N = 13), standard Roux-en-Y gastric bypass (RYGB; N = 205), and distal Roux-en-Y gastric bypass (DRY; N = 9). By 6 months postoperatively, patients had a >/=15% mean reduction in TC and a >/=50% mean reduction in triglycerides, both of which were significant in comparison with preoperative levels (P </=0.05). Mean HDL-C levels had increased significantly vs. preoperative levels by 12 months postoperative y (P <0.05) and continued to increase through 5 years. By 18 months both HDL-C and TC were significantly lower after DRY than after GP or RYGB. In 91 patients who were followed for 2 years or longer (mean 48 +/- 25 months), mean excess weight loss was 55% with mean body mass index reduced from 48 to 33 kg/m(2). This group was divided into patients whose weight remained stable (N = 54) and patients who regained >/=15% of their lost weight or lost less than 50% of excess weight (N = 37). Although mean excess weight loss and body mass index were significantly different between the two groups (P <0.0001) at 2 years, there was no difference in the lipid profile (TC/HDL) between the two groups at any interval through 5 years. These results show that abnormal lipid profiles can be permanently improved after gastric bariatric surgery and are not adversely affected by mediocre weight loss or regaining >/=15% of lost weight. DRY appears to be a superior operation for TC reduction in comparison with GP and RYGB.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11077320     DOI: 10.1016/s1091-255x(00)80087-6

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  20 in total

1.  Gastric bypass operation for obesity.

Authors:  M A Fobi; H Lee; R Holness; D Cabinda
Journal:  World J Surg       Date:  1998-09       Impact factor: 3.352

2.  The effect of rapid weight loss due to jejunoileal bypass on total cholesterol and high-density lipoprotein.

Authors:  G M Dobrea; R G Wieland; M W Johnson
Journal:  Am J Clin Nutr       Date:  1981-10       Impact factor: 7.045

3.  Serum lipids after gastric bypass surgery for morbid obesity.

Authors:  R E Brolin; H A Kenler; A C Wilson; P T Kuo; R P Cody
Journal:  Int J Obes       Date:  1990-11

4.  Lipid Research Clinics Program reference values for hyperlipidemia and hypolipidemia.

Authors:  B M Rifkind; P Segal
Journal:  JAMA       Date:  1983-10-14       Impact factor: 56.272

5.  Gastric bypass: analysis of weight loss and factors determining success.

Authors:  J D Halverson; R E Koehler
Journal:  Surgery       Date:  1981-09       Impact factor: 3.982

6.  Impact of gastric restrictive surgery on hypertension in the morbidly obese.

Authors:  E F Foley; P N Benotti; B C Borlase; J Hollingshead; G L Blackburn
Journal:  Am J Surg       Date:  1992-03       Impact factor: 2.565

7.  Cholesterol and mortality. 30 years of follow-up from the Framingham study.

Authors:  K M Anderson; W P Castelli; D Levy
Journal:  JAMA       Date:  1987-04-24       Impact factor: 56.272

8.  Improvement in heart disease risk factors after gastric bypass.

Authors:  J J Gleysteen; J J Barboriak
Journal:  Arch Surg       Date:  1983-06

9.  Lipoprotein levels in morbidly obese patients with massive, surgically-induced weight loss.

Authors:  B Gonen; J D Halverson; G Schonfeld
Journal:  Metabolism       Date:  1983-05       Impact factor: 8.694

10.  Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study.

Authors:  H B Hubert; M Feinleib; P M McNamara; W P Castelli
Journal:  Circulation       Date:  1983-05       Impact factor: 29.690

View more
  14 in total

1.  Biliopancreatic Diversion Decreases Postprandial Apolipoprotein A-IV Levels in Mildly Obese Individuals with Type 2 Diabetes Mellitus: a Prospective Study.

Authors:  Everton Cazzo; José Carlos Pareja; Bruno Geloneze; Elinton Adami Chaim; Maria Rita Lazzarini Barreto; Daniéla Oliveira Magro
Journal:  Obes Surg       Date:  2017-04       Impact factor: 4.129

2.  Long-term Management of Patients After Weight Loss Surgery.

Authors:  William S Richardson; Amber M Plaisance; Laura Periou; Jennifer Buquoi; Deanna Tillery
Journal:  Ochsner J       Date:  2009

3.  Cost-effectiveness analysis of cholecystectomy during Roux-en-Y gastric bypass for morbid obesity.

Authors:  Jaime Benarroch-Gampel; David R Lairson; Casey A Boyd; Kristin M Sheffield; Vivian Ho; Taylor S Riall
Journal:  Surgery       Date:  2012-09       Impact factor: 3.982

4.  One year improvements in cardiovascular risk factors: a comparative trial of laparoscopic Roux-en-Y gastric bypass vs. adjustable gastric banding.

Authors:  Gavitt A Woodard; Joseph Peraza; Stephanie Bravo; Loren Toplosky; Tina Hernandez-Boussard; John M Morton
Journal:  Obes Surg       Date:  2010-02-26       Impact factor: 4.129

5.  Impact of restrictive (sleeve gastrectomy) vs hybrid bariatric surgery (Roux-en-Y gastric bypass) on lipid profile.

Authors:  D Benaiges; J A Flores-Le-Roux; J Pedro-Botet; J M Ramon; A Parri; M Villatoro; M J Carrera; M Pera; E Sagarra; L Grande; A Goday
Journal:  Obes Surg       Date:  2012-08       Impact factor: 4.129

6.  Effects of weight loss, induced by gastric bypass surgery, on HDL remodeling in obese women.

Authors:  Bela F Asztalos; Michael M Swarbrick; Ernst J Schaefer; Gerard E Dallal; Katalin V Horvath; Masumi Ai; Kimber L Stanhope; Iselin Austrheim-Smith; Bruce M Wolfe; Mohamed Ali; Peter J Havel
Journal:  J Lipid Res       Date:  2010-08       Impact factor: 5.922

7.  Gastric bypass and sleeve gastrectomy: the same impact on IL-6 and TNF-α. Prospective clinical trial.

Authors:  Elaine Cristina Viana; Karine L Araujo-Dasilio; Gustavo Peixoto Soares Miguel; Josefina Bressan; Elenice Moreira Lemos; Margareth Ribeiro Moyses; Gláucia Rodrigues de Abreu; João Luiz Moreira Coutinho de Azevedo; Perseu Seixas Carvalho; Maria Rita S Passos-Bueno; Flávia Imbroisi Valle Errera; Nazaré Souza Bissoli
Journal:  Obes Surg       Date:  2013-08       Impact factor: 4.129

8.  Metabolic syndrome after laparoscopic bariatric surgery.

Authors:  Clare Nugent; Chunhong Bai; Hazem Elariny; Priya Gopalakrishnan; Caitlin Quigley; Michael Garone; Mariam Afendy; Oscar Chan; Angela Wheeler; Arian Afendy; Zobair M Younossi
Journal:  Obes Surg       Date:  2008-04-09       Impact factor: 4.129

9.  Changes in lipid profile and insulin resistance in obese patients after Scopinaro biliopancreatic diversion.

Authors:  Magdalena Vila; Olga Ruíz; Mar Belmonte; Maria Riesco; Antonia Barceló; Gerardo Perez; Jose Moreiro; Ramon Salinas
Journal:  Obes Surg       Date:  2009-01-06       Impact factor: 4.129

10.  Metabolite profiling identifies candidate markers reflecting the clinical adaptations associated with Roux-en-Y gastric bypass surgery.

Authors:  David M Mutch; Jens C Fuhrmann; Dietrich Rein; Jan C Wiemer; Jean-Luc Bouillot; Christine Poitou; Karine Clément
Journal:  PLoS One       Date:  2009-11-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.